CERo Therapeutics Holdings, Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CERO and buy or sell other stocks, ETFs, and their options commission-free!About CERO
CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors.
CEOChristopher B. Ehrlich
CEOChristopher B. Ehrlich
Employees9
Employees9
HeadquartersOakland, California
HeadquartersOakland, California
Founded2021
Founded2021
Employees9
Employees9
CERO Key Statistics
Market cap19.30M
Market cap19.30M
Price-Earnings ratio-11.94
Price-Earnings ratio-11.94
Dividend yield—
Dividend yield—
Average volume136.31M
Average volume136.31M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1,280.00
52 Week high$1,280.00
52 Week low$3.99
52 Week low$3.99
Stock Snapshot
The current CERo Therapeutics Holdings, Inc.(CERO) stock price is $0.10, with a market capitalization of 19.3M. The stock trades at a price-to-earnings (P/E) ratio of -11.94.
On 2026-03-18, CERo Therapeutics Holdings, Inc.(CERO) stock opened at —, reached a high of —, and a low of —.
The CERo Therapeutics Holdings, Inc.(CERO)'s current trading volume is 0, compared to an average daily volume of 136.31M.
In the last year, CERo Therapeutics Holdings, Inc.(CERO) shares hit a 52-week high of $1,280.00 and a 52-week low of $3.99.
In the last year, CERo Therapeutics Holdings, Inc.(CERO) shares hit a 52-week high of $1,280.00 and a 52-week low of $3.99.
People also own
Based on the portfolios of people who own CERO. This list is generated using Robinhood data, and it’s not a recommendation.